Russell Stuermann, MD
Pain Medicine · Bossier City, LANPI 1306027438
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,472 of the $5,071 with a category attached, or 88.2%. It is spread thinly across 22 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,152 and has fallen 50.0% since, to $576 in 2025.
Across 181 payments — averaging $28.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Abbott$894
- Nevro Corp.$660
- Medtronic$526
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$500
- Averitas Pharma Inc.$287
- plus $1K from 16 others
What the payments were for
- Travel & lodging$1583%
- Food & beverage$4,47288%
- Education$4419%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 26 | $1,125 |
| Abbott | 15 | $894 |
| Nevro Corp. | 12 | $660 |
| Medtronic(2 entities) | 5 | $526 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 31 | $500 |
| Averitas Pharma Inc. | 23 | $287 |
| AbbVie | 24 | $236 |
| Pfizer | 14 | $231 |
| Vertos Medical, Inc. | 4 | $121 |
| Scilex Pharmaceuticals Inc. | 6 | $108 |
| Saluda Medical Americas, Inc. | 5 | $107 |
| Collegium Pharmaceutical, Inc. | 3 | $47 |
| Biohaven Pharmaceuticals, Inc. | 3 | $41 |
| Amgen | 1 | $31 |
| Globus Medical | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| Redhill Biopharma Inc. | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Baudax Bio Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $17 |
| Tonix Medicines, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,071 in reported general payments places this provider in the 60th percentile of 97 pain medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 84 | $60,885 |
| Buprenorphine | 232 | $48,386 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,055 | $38,817 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,251 | $31,901 |
| MovantikNaloxegol Oxalate | 45 | $20,869 |
| OxycontinOxycodone Hcl | 30 | $15,349 |
| Gabapentin | 1,233 | $14,267 |
| LinzessLinaclotide | 22 | $11,555 |
| Tramadol Hcl ErTramadol Hcl | 187 | $10,559 |
| Pregabalin | 594 | $8,388 |
| Xtampza ErOxycodone Myristate | 15 | $8,266 |
| Oxycodone Hcl | 301 | $5,858 |
| Fentanyl | 51 | $5,283 |
| Tramadol Hcl | 643 | $4,591 |
| Morphine Sulfate ErMorphine Sulfate | 137 | $3,689 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $47 | $69,15199 claims |
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate | $21 | $49,159264 claims |
| Redhill Biopharma Inc.Movantik | $23 | $20,86945 claims |
| AbbVieLinzess | $236 | $11,55522 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 97 pain medicine providers in Louisiana.
Other pain medicine in Bossier City
- John NolesBossier City$7K
- David HirschBossier City$5K
- Thomas MyersMandeville$118K
- Alan KayeNew Orleans$76K
- Derrick DeanTerrytown$68K
- Hazem EissaNew Orleans$50K
- Robert OwensNew Orleans$47K
- Gassan ChaibanLake Charles$30K
- Yashar EshraghiNew Orleans$22K
- Prathima AnandiShreveport$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.